It's good news, but, unfortunately there always seems to be a but these days, we will need a JV to progress it further. Asset wise CXY is undervalued, not much else to say at this stage until the labs are back.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025